ANPC AnPac Bio-Medical Science Co., Ltd. Stock Quote

ANPC [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	37.84%	Shs Outstand	10.95M	Perf Week	1.59%
Market Cap	63.89M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.00%	Shs Float	1.33M	Perf Month	-6.21%
Income	-	PEG	-	EPS next Q	-0.16	Inst Own	0.63%	Short Float	0.72%	Perf Quarter	63.07%
Sales	-	P/S	-	EPS this Y	-140.30%	Inst Trans	-	Short Ratio	0.01	Perf Half Y	-0.17%
Book/sh	0.34	P/B	16.88	EPS next Y	41.40%	ROA	-	Target Price	-	Perf Year	-
Cash/sh	0.13	P/C	42.59	EPS next 5Y	-	ROE	-	52W Range	3.15 - 12.18	Perf YTD	8.30%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-392.20%	52W High	-52.87%	Beta	-
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	-	Gross Margin	-	52W Low	82.22%	ATR	0.44
Employees	101	Current Ratio	0.90	Sales Q/Q	-37.90%	Oper. Margin	-	RSI (14)	55.95	Volatility	4.42% 6.11%
Optionable	No	Debt/Eq	0.24	EPS Q/Q	-83.20%	Profit Margin	-	Rel Volume	0.02	Prev Close	5.71
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.59M	Price	5.74
Recom	2.00	SMA20	2.10%	SMA50	17.97%	SMA200	-1.01%	Volume	24,725	Change	0.53%

Dec-15-20 07:45AM	ANPC: Updated Guidance Prompts Target Increase Zacks Small Cap Research +7.37%
Dec-14-20 07:30AM	AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases GlobeNewswire +35.07%
Dec-10-20 11:01PM	News Flash: Analysts Just Made An Incredible Upgrade To Their AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Forecasts Simply Wall St.
Dec-04-20 04:01PM	Anpac Bio Announces Change of Auditor GlobeNewswire -7.59%
Nov-25-20 11:01AM	Why These 3 Health Care Stocks Are Trading Higher Today Benzinga +104.00%
07:30AM	AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020 GlobeNewswire
Nov-16-20 04:01PM	Anpac Bio Announces Appointment of New Independent Director GlobeNewswire
Nov-10-20 07:30AM	AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing GlobeNewswire
Nov-02-20 07:30AM	AnPac Bios Investee Company in China Received COVID-19 Nucleic Acid Test Certification and Began Volume Tests and Collaborations with AnPac Bio GlobeNewswire +22.21%
03:30AM	ANPC: Next Gen Cancer Screening Zacks Small Cap Research
Oct-26-20 06:45AM	Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer GlobeNewswire
Oct-13-20 05:00AM	ANPC: AnPac Cancer Differentiation Analysis (CDA) Technology Zacks Small Cap Research
Oct-07-20 07:00AM	AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements GlobeNewswire
Oct-01-20 07:30AM	AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million GlobeNewswire
Sep-23-20 08:15AM	Tiger Asia Intelligence reiterates a Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) PR Newswire
Sep-15-20 07:00AM	AnPac Bio Receives Major Immunology Testing Contract GlobeNewswire
Sep-11-20 08:05AM	The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review Benzinga
Sep-10-20 06:53AM	AnPac Bio Reports First Six Months of 2020 Financial Results GlobeNewswire -8.75%
Sep-08-20 10:04AM	Company News for Sep 8, 2020 Zacks -8.93%
Sep-04-20 07:30AM	AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study GlobeNewswire +7.23%
Aug-28-20 08:00AM	AnPac Bio to Report its First Six Months 2020 Financial Results on Thursday, September 10, 2020 GlobeNewswire -5.22%
Aug-24-20 07:30AM	AnPac Bio Philadelphia Lab Gains U.S. CLIA Lab Certification GlobeNewswire
Aug-11-20 07:30AM	AnPac Bio Opens US Philadelphia Lab Operations GlobeNewswire -7.88%
Aug-07-20 07:30AM	AnPac Bio Validating Approved COVID-19 Antibody Test GlobeNewswire +38.43%
Aug-04-20 07:30AM	AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness GlobeNewswire
Jul-29-20 08:26AM	AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests GlobeNewswire +28.21%
Jul-13-20 08:40AM	AnPac Bio Completed 1st Half Year with Increased ASP and Revenue GlobeNewswire
Jun-26-20 08:00AM	AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening GlobeNewswire
Jun-22-20 08:46AM	AnPac Bio Launches New Immunology Test Product Line GlobeNewswire -5.72%
Jun-19-20 08:46AM	AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening GlobeNewswire +8.87%
Jun-10-20 04:20PM	Tiger Asia Intelligence reiterate Buy rating on AnPac Bio, Ltd (NASDAQ:ANPC) PR Newswire
Jun-03-20 07:39AM	The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study Benzinga
Jun-02-20 05:00PM	AnPac Bio Announces Appointment of New Chief Financial Officer GlobeNewswire
May-26-20 08:00AM	AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States GlobeNewswire
May-18-20 08:30AM	AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019 GlobeNewswire
08:24AM	AnPac Files Its Annual Report on Form 20-F GlobeNewswire
May-11-20 06:46AM	AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States GlobeNewswire +10.39%
Apr-30-20 09:15AM	ANPC: A Blood Test for Cancer Diagnosis Zacks Small Cap Research
05:00AM	ANPC: A Blood Test for Cancer Diagnosis Zacks Small Cap Research
Mar-30-20 08:30AM	Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd PR Newswire
Mar-27-20 08:00AM	AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists GlobeNewswire
Mar-24-20 07:30AM	AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States PR Newswire +11.53%
Mar-03-20 08:30AM	AnPac Bio-Medical Science Announces Cooperation with Dragon Gate Investment Partners PR Newswire -6.00%
Feb-27-20 09:00AM	AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project PR Newswire
Feb-06-20 08:15AM	AnPac Bio Gains Two New Insurance Customers PR Newswire
Feb-03-20 09:17AM	WestPark Capital announces trading of $16,000,000 IPO for AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) GlobeNewswire
Jan-30-20 02:09PM	Univest Securities, LLC. Announces Trading of IPO for its Client AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), Marking the 1st IPO in 2020 Univest Acts as a Joint Book Running Manager GlobeNewswire
12:47PM	AnPac Bio Announces Pricing of Initial Public Offering PR Newswire

Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience